To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- Hobit Turns Immune Cells Into Killers - Can killer ILCs be made therapeutically useful?
- LEDs from bacterial production - Sustainable light sources
- Merck Announces Joint Agreement With ImClone and Bristol-Myers Squibb for Erbitux in Japan - Co-development and co-commercialization of Erbitux in metastatic colorectal cancer upon health authority approval
